Increased Prevalence of Metabolic Syndrome Associated with Rheumatoid Arthritis in Patients Without Clinical Cardiovascular Disease

Overview

Journal J Rheumatol

Specialty Rheumatology

Date 2010 Oct 19

PMID 20952464

Citations 27

Authors

Cynthia S Crowson

Elena Myasoedova

John M Davis 3rd

Eric L Matteson

Veronique L Roger

Terry M Therneau

Patrick Fitz-Gibbon

Richard J Rodeheffer

Sherine E Gabriel

Affiliations

Soon will be listed here.

Abstract

Objective: to examine whether patients with rheumatoid arthritis (RA) with no overt cardiovascular disease (CVD) have a higher prevalence of metabolic syndrome (MetS) than subjects without RA or CVD. We also examined whether RA disease characteristics are associated with the presence of MetS in RA patients without CVD.

Methods: subjects from a population-based cohort of patients who fulfilled 1987 American College of Rheumatology criteria for RA between January 1, 1980, and December 31, 2007, were compared to non-RA subjects from the same population. All subjects with any history of CVD were excluded. Waist circumference, body mass index (BMI), and blood pressure were measured during the study visit. Data on CVD, lipids, and glucose measures were ascertained from medical records. MetS was defined using NCEP/ATP III criteria. Differences between the 2 cohorts were examined using logistic regression models adjusted for age and sex.

Results: the study included 232 RA subjects without CVD and 1241 non-RA subjects without CVD. RA patients were significantly more likely to have increased waist circumference and elevated blood pressure than non-RA subjects, even though BMI was similar in both groups. Significantly more RA patients were classified as having MetS. In RA patients, MetS was associated with Health Assessment Questionnaire Disability Index, large-joint swelling, and uric acid levels, but not with C-reactive protein or RA therapies.

Conclusion: among subjects with no history of CVD, patients with RA are more likely to have MetS than non-RA subjects. MetS in patients with RA was associated with some measures of disease activity.

Citing Articles

Prevalence of Metabolic Syndrome in Patients With Rheumatoid Arthritis: An Updated Systematic Review and Meta-Analysis.

Cai W, Tang X, Pang M Front Med (Lausanne). 2022; 9:855141.

PMID: 35462993 PMC: 9024100. DOI: 10.3389/fmed.2022.855141.

Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters.

Pandey P, Swami A, Biswas T, Thakuria R Arch Rheumatol. 2018; 32(1):46-52.

PMID: 30375525 PMC: 6190937. DOI: 10.5606/ArchRheumatol.2017.5949.

Metabolic syndrome in adults with a history of juvenile arthritis.

Sule S, Fontaine K Open Access Rheumatol. 2018; 10:67-72.

PMID: 29922101 PMC: 5995292. DOI: 10.2147/OARRR.S157229.

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.

Peluso R, Caso F, Tasso M, Ambrosino P, Di Minno M, Lupoli R Rev Recent Clin Trials. 2018; 13(3):199-209.

PMID: 29542417 PMC: 6691775. DOI: 10.2174/1574887113666180314105511.

Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes.

Herly M, Stengaard-Pedersen K, Horslev-Petersen K, Hetland M, Ostergaard M, Christensen R BMJ Open. 2017; 7(4):e014816.

PMID: 28391237 PMC: 5541299. DOI: 10.1136/bmjopen-2016-014816.

References

Pereira R, de Carvalho J, Bonfa E . Metabolic syndrome in rheumatological diseases. Autoimmun Rev. 2009; 8(5):415-9. DOI: 10.1016/j.autrev.2009.01.001. View

Galassi A, Reynolds K, He J . Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006; 119(10):812-9. DOI: 10.1016/j.amjmed.2006.02.031. View

Wasko M, Hubert H, Lingala V, Elliott J, Luggen M, Fries J . Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA. 2007; 298(2):187-93. DOI: 10.1001/jama.298.2.187. View

Sidiropoulos P, Karvounaris S, Boumpas D . Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther. 2008; 10(3):207. PMC: 2483433. DOI: 10.1186/ar2397. View

. Screening adults for lipid disorders: recommendations and rationale. Am J Prev Med. 2001; 20(3 Suppl):73-6. View

Chung C, Oeser A, Solus J, Avalos I, Gebretsadik T, Shintani A . Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2007; 196(2):756-63. DOI: 10.1016/j.atherosclerosis.2007.01.004. View

Sabio J, Zamora-Pasadas M, Jimenez-Jaimez J, Albadalejo F, Vargas-Hitos J, Rodriguez del Aguila M . Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus. 2008; 17(9):849-59. DOI: 10.1177/0961203308093554. View

Toms T, Panoulas V, John H, Douglas K, Kitas G . Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther. 2009; 11(4):R110. PMC: 2745792. DOI: 10.1186/ar2765. View

Kremers H, Crowson C, Gabriel S . Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am. 2004; 30(4):819-34, vii. DOI: 10.1016/j.rdc.2004.07.010. View

10.

Panoulas V, Douglas K, Milionis H, Nightingale P, Kita M, Klocke R . Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis. J Hum Hypertens. 2007; 22(3):177-82. DOI: 10.1038/sj.jhh.1002298. View

11.

Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View

12.

Giles J, Ling S, Ferrucci L, Bartlett S, Andersen R, Towns M . Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008; 59(6):807-15. PMC: 2670994. DOI: 10.1002/art.23719. View

13.

Jacobsen S, Mahoney D, Redfield M, Bailey K, Burnett Jr J, Rodeheffer R . Participation bias in a population-based echocardiography study. Ann Epidemiol. 2004; 14(8):579-84. DOI: 10.1016/j.annepidem.2003.11.001. View

14.

Ridker P, Buring J, Cook N, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3):391-7. DOI: 10.1161/01.cir.0000055014.62083.05. View

15.

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

16.

Nicola P, Maradit-Kremers H, Roger V, Jacobsen S, Crowson C, Ballman K . The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005; 52(2):412-20. DOI: 10.1002/art.20855. View

17.

Maradit-Kremers H, Crowson C, Nicola P, Ballman K, Roger V, Jacobsen S . Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52(2):402-11. DOI: 10.1002/art.20853. View

18.

Redfield M, Jacobsen S, Burnett Jr J, Mahoney D, Bailey K, Rodeheffer R . Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2):194-202. DOI: 10.1001/jama.289.2.194. View

19.

Toms T, Panoulas V, Douglas K, Griffiths H, Kitas G . Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2008; 10(6):R145. PMC: 2656250. DOI: 10.1186/ar2578. View

20.

Ervin R . Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009; (13):1-7. View